Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction

被引:64
作者
Orn, S
Cleland, JGF
Romo, M
Kjekshus, J
Dickstein, K
机构
[1] Cent Hosp Rogaland, Stavanger, Norway
[2] Univ Bergen, Stavanger, Norway
[3] Univ Hull, Kingston Upon Hull, Yorks, England
[4] Univ Helsinki, FIN-00014 Helsinki, Finland
[5] Univ Oslo, N-0316 Oslo, Norway
关键词
autopsy; mode of death; cause of death; myocardial infarction; heart failure;
D O I
10.1016/j.amjmed.2005.02.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: The development of left ventricular systolic dysfunction or heart failure following an acute myocardial infarction (MI) is a powerful marker of an adverse prognosis. Recurrent MI could be an important cause of death, either directly or by provoking arrhythmias. METHODS: The OPTIMAAL trial randomized 5477 patients with heart failure or evidence of left ventricular dysfunction following acute MI to losartan or captopril. Over a follow-up of 2.7 years, there were 946 deaths. Of the 180 (19%) of these deaths for which autopsy reports were available, acute MI was found in 57% (102 of 180) of the autopsies. By comparison, an endpoints adjudication committee using clinical data attributed death to acute MI in only 29 cases. An acute MI was found at autopsy in 55% (37 of 67) of the deaths that had been classified as due to an arrhythmia and in 81% (21 of 26) of the deaths classified as due to progressive heart failure. Including autopsy diagnoses, the rate of acute MI in patients who died suddenly was independent of the time elapsed since the index MI, but in patients not classified as dying suddenly, there was a time-related decrease in recurrent MI from 78% in the first 30 days to 30% by the end of follow-up. However, only 19% of patients who died underwent autopsy, so recurrent MI may have been substantially more common and perhaps had a different relation to time since the index MI if more patients had undergone autopsy. CONCLUSIONS: In patients with evidence of major cardiac dysfunction after MI, recurrent MI found at autopsy is common and has often not been clinically detected. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:752 / 758
页数:7
相关论文
共 18 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]  
*AVID INV, 1997, NEW ENGL J MED, V337, P5176
[3]   Cardiovascular critical event pathways for the progression of heart failure -: A report from the ATLAS study [J].
Cleland, JGF ;
Thygesen, K ;
Uretsky, BF ;
Armstrong, P ;
Horowitz, JD ;
Massie, B ;
Packer, M ;
Poole-Wilson, PA ;
Rydén, L .
EUROPEAN HEART JOURNAL, 2001, 22 (17) :1601-1612
[4]  
Cleland JGF, 1997, EUR HEART J, V18, P41
[5]   Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial [J].
Dargie, HJ ;
Colucci, Y ;
Ford, I ;
Sendon, JLL ;
Remme, W ;
Sharpe, N ;
Blank, A ;
Holcslaw, TL .
LANCET, 2001, 357 (9266) :1385-1390
[6]  
DAVID TJ, 1992, J ROY SOC MED, V85, P1
[7]   PREVALENCE OF TOTAL CORONARY-OCCLUSION DURING THE EARLY HOURS OF TRANSMURAL MYOCARDIAL-INFARCTION [J].
DEWOOD, MA ;
SPORES, J ;
NOTSKE, R ;
MOUSER, LT ;
BURROUGHS, R ;
GOLDEN, MS ;
LANG, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (16) :897-902
[8]   Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial [J].
Dickstein, K ;
Kjekshus, J .
LANCET, 2002, 360 (9335) :752-760
[9]   Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction - A meta-analysis of randomized clinical trials [J].
Domanski, MJ ;
Exner, DV ;
Borkowf, CB ;
Geller, NL ;
Rosenberg, Y ;
Pfeffer, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (03) :598-604
[10]   SUDDEN CORONARY DEATH - FREQUENCY OF ACTIVE CORONARY LESIONS, INACTIVE CORONARY LESIONS, AND MYOCARDIAL-INFARCTION [J].
FARB, A ;
TANG, AL ;
BURKE, AP ;
SESSUMS, L ;
LIANG, YH ;
VIRMANI, R .
CIRCULATION, 1995, 92 (07) :1701-1709